159 evolution "https:" "https:" "https:" "https:" "UCL" research jobs at University of Washington
Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
for future career opportunities. Job Description Primary Duties & Responsibilities: More information about the Brossier Lab can be found at https://brossierlab.wustl.edu/ . Under the direction of the PI or lab
-
immune strategies that enable survival during phage attack. In addition, another major focus of our research is protein engineering and the development of new molecular tools based on these proteolytic
-
are strongly encouraged to apply. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2
-
didactic activities to promote professional development in cardiovascular care. The 2026/2027 CV APP Fellowship will begin on November 2, 2026 and complete on October 31, 2027. Given the licensing and
-
dozens of studies sponsored through the NIH, Department of Defense, National MS Society, and various pharmaceutical companies. About the research: https://trottermultiplesclerosiscenter.wustl.edu/clinical
-
your family, including dependent undergraduate-level college tuition up to 100% at WashU and 40% elsewhere after seven years with us. For policies, detailed benefits, and eligibility, please visit: https
-
. The overarching mission of I-LABS is to understand the mechanisms of human learning, especially in early development. More information about I-LABS can be found at: (http://ilabs.washington.edu ). This I-LABS
-
Scheduled Hours 40 Position Summary The WashU Medicine ALS Center (https://alscenter.wustl.edu) provides quality care, state-of-the-art treatment, precision medicine, and research opportunities
-
variants in inborn errors of immunity. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2
-
role in immune modulation. In addition, the lab also has a robust program in development of small molecule inhibitors as therapeutic option for these cancers. The lab has previously identified multiple